Nasus Pharma Ltd

CUSIP M7071P109ORD SHSNSRXQ4 2025

Nasus Pharma Ltd — Owners — 13D/13G Beneficial Ownership · FBInvestor

13D / 13G Filings

Schedule 13D/13G on record

Beneficial Filers

Distinct reporting persons

Largest Stake

21.1%

Max % of class reported

Institutional Holders

13F filers (latest quarter)

4 filings · latest Nov 13, 2025

#	Filed	Reporting Person	Form	% of Class	Shares	Filing
1	Nov 13, 2025	Dr. Ronnie Hershman	13G	15.3%	1.38M	SEC
2	Nov 12, 2025	Dr. Dalia Megiddo	13G	20.9%	1.89M	SEC
3	Nov 10, 2025	Udi Gilboa	13G	21.1%	1.90M	SEC

Largest reported positions · latest quarter

#	Fund	Shares	Value
1	Morgan Stanley	2.0K	$18.3K
2	Ubs Group AG	378	$3.5K